Brain and other central nervous system tumor statistics, 2021.
Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS.
CA Cancer J Clin. 2021 Sep;71(5):381-406. doi: 10.3322/caac.21693. Epub 2021 Aug 24.
Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S, Batchelor TT, Gonzalez Castro LN.
Cancer. 2022 Jan 1;128(1):47-58. doi: 10.1002/cncr.33918. Epub 2021 Oct 11.
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN.
JAMA Oncol. 2022 Oct 1;8(10):1493-1501. doi: 10.1001/jamaoncol.2022.2844.
CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
Ostrom QT, Price M, Ryan K, Edelson J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS.
Neuro Oncol. 2022 Sep 6;24(Suppl 3):iii1-iii38. doi: 10.1093/neuonc/noac161.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS.
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96. doi: 10.1093/neuonc/noaa200.
Pediatric Neuro-Oncology.
Malbari F.
Neurol Clin. 2021 Aug;39(3):829-845. doi: 10.1016/j.ncl.2021.04.005. Epub 2021 Jun 10.
Central nervous system.
Adamson DC, Rasheed BA, McLendon RE, Bigner DD.
Cancer Biomark. 2010;9(1-6):193-210. doi: 10.3233/CBM-2011-0177.
Neuro-oncologic Emergencies.
Suarez-Meade P, Marenco-Hillembrand L, Sherman WJ.
Curr Oncol Rep. 2022 Aug;24(8):975-984. doi: 10.1007/s11912-022-01259-3. Epub 2022 Mar 30.
Advances in Central Nervous System Tumor Classification.
Malta TM, Snyder J, Noushmehr H, Castro AV.
Adv Exp Med Biol. 2023;1416:121-135. doi: 10.1007/978-3-031-29750-2_10.
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma.
Heming M, Haessner S, Wolbert J, Lu IN, Li X, Brokinkel B, Müther M, Holling M, Stummer W, Thomas C, Schulte-Mecklenbeck A, de Faria F, Stoeckius M, Hailfinger S, Lenz G, Kerl K, Wiendl H, Meyer Zu Hörste G, Grauer OM.
Genome Med. 2022 Sep 24;14(1):109. doi: 10.1186/s13073-022-01110-1.
